Cited 0 times in
Immunization With RANKL Inhibits Osteolytic Bone Metastasis in Breast Cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김보라 | - |
dc.date.accessioned | 2023-06-19T02:22:36Z | - |
dc.date.available | 2023-06-19T02:22:36Z | - |
dc.date.issued | 2022-01 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194839 | - |
dc.description.abstract | Breast cancer cells often metastasize to bone. Accumulating evidence suggests that inhibiting the receptor activator of nuclear factor-κB ligand (RANKL) not only leads to reduced bone metastasis of breast cancer but also has antitumoral effects. Here, we used mutant receptor activator of nuclear factor-κB ligand (RANKLM) as a vaccine for active immunization to induce antibodies for immunotherapy of bone metastatic cancer. We investigated whether anti-RANKL antibodies inhibit osteolytic bone metastasis in vitro and in a murine model. MC3T3 cells stimulated by MDA-MB-231 culture medium secreted growth differentiation factor-15 (GDF-15), which induced the nuclear factor-κB signaling cascade. In addition, RANKLM treatment-induced reduction of intraosseous growth of MDA-MB-231 cells correlated with decreased GDF-15 expression, a reduced number of osteolytic lesions, and slower tumor progression. In addition, vaccination with RANKLM led to significant improvement in overall survival and skeletal metastasis in tumor-bearing mice. Induction of anti-RANKL antibodies by RANKLM decreased GDF-15 production by deactivating nuclear factor-κB signaling, which in turn inhibited metastasis of MDA-MB-231 cells to bone. Taken together, the results demonstrate a role for RANKLM immunization in preventing bone metastasis of breast cancer. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.relation.isPartOf | J. Immunother. | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Immunization With RANKL Inhibits Osteolytic Bone Metastasis in Breast Cancer | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Anatomy (해부학교실) | - |
dc.contributor.googleauthor | Bora Kim | - |
dc.contributor.googleauthor | Yong Jin Cho | - |
dc.contributor.googleauthor | Mineon Park | - |
dc.contributor.googleauthor | Wonbong Lim | - |
dc.identifier.doi | 10.1097/CJI.0000000000000393 | - |
dc.contributor.localId | A06450 | - |
dc.identifier.pmid | 34545011 | - |
dc.identifier.url | https://journals.lww.com/immunotherapy-journal/Fulltext/2022/01000/Immunization_With_RANKL_Inhibits_Osteolytic_Bone.1.aspx | - |
dc.subject.keyword | Animals | - |
dc.subject.keyword | Breast Neoplasms* / therapy | - |
dc.subject.keyword | Cell Line, Tumor | - |
dc.subject.keyword | Female | - |
dc.subject.keyword | Humans | - |
dc.subject.keyword | Immunization | - |
dc.subject.keyword | Mice | - |
dc.subject.keyword | Osteoclasts | - |
dc.subject.keyword | RANK Ligand* | - |
dc.subject.keyword | Vaccination | - |
dc.contributor.alternativeName | Kim, Bora | - |
dc.contributor.affiliatedAuthor | 김보라 | - |
dc.citation.volume | 45 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 12 | - |
dc.identifier.bibliographicCitation | J. Immunother., Vol.45(1) : 1-12, 2022-01 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.